Provided by Tiger Trade Technology Pte. Ltd.

SITC

27.640
+0.4801.77%
Volume:5.09M
Turnover:139.30M
Market Cap:74.63B
PE:9.12
High:27.640
Open:27.340
Low:26.780
Close:27.160
52wk High:32.179
52wk Low:13.698
Shares:2.70B
HK Float Shares:2.70B
Volume Ratio:0.86
T/O Rate:0.19%
Dividend:2.75
Dividend Rate:9.93%
EPS(LYR):3.030
ROE:55.92%
ROA:25.43%
PB:3.73
PE(LYR):9.12
PS:2.80

Loading ...

SITC Hosts 2025 Shanghai Regional Employee Symposium

Reuters
·
Nov 21, 2025

SITC Crew Services (Qingdao) Passes SRPS Annual Audit

Reuters
·
Nov 20, 2025

Shipping Stocks Decline as Houthis Announce Ceasefire on Commercial Vessel Attacks; Market Eyes Red Sea Navigation Prospects

Stock News
·
Nov 17, 2025

SITC International Holdings Highlights ESG Commitment in Wuhan Team Building Activity

Reuters
·
Nov 17, 2025

SITC International Holdings Insiders Sold US$125m Of Shares Suggesting Hesitancy

Simply Wall St.
·
Nov 16, 2025

SITC International Opens New Supply Chain Management Company in Foshan

Reuters
·
Nov 12, 2025

SITC Ships Management Co., Ltd. Passes Chinese Flag DOC Initial Audit

Reuters
·
Nov 12, 2025

PDS Biotechnology Announces Translational Data Showing Strong Immunological and Clinical Activity of PDS0101 and PDS01ADC Presented at SITC 2025

GlobeNewswire
·
Nov 10, 2025

Calidi Biotherapeutics Presents New Data on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting and Holds Its First Investor Day at SITC

GlobeNewswire
·
Nov 10, 2025

Press Release: Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

Dow Jones
·
Nov 07, 2025

Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

GlobeNewswire
·
Nov 07, 2025

IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

GlobeNewswire
·
Nov 07, 2025

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025

GlobeNewswire
·
Nov 07, 2025

Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting

GlobeNewswire
·
Nov 07, 2025

HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting

GlobeNewswire
·
Nov 07, 2025

Plus Therapeutics Highlights ReSPECT-LM Clinical Trial Results at 40th SITC Annual Meeting, Melanoma Research Foundation Brain Metastases Summit 4.0

GlobeNewswire
·
Nov 06, 2025

Crescent Biopharma to Present Preclinical Data for CR-001, a PD-1 x VEGF Bispecific Antibody, at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting

GlobeNewswire
·
Nov 04, 2025

Calidi Biotherapeutics Announces Investor Event to be Held on Friday, November 7th at the 2025 SITC Annual Meeting

GlobeNewswire
·
Nov 04, 2025

SITC International (01308) Announces October 2025 Monthly Return

Bulletin Express
·
Nov 04, 2025

SITC International Holdings Highlights Team Building and Green Development Initiatives

Reuters
·
Nov 03, 2025